Teri E Klein

Teri E Klein

UNVERIFIED PROFILE

Are you Teri E Klein?   Register this Author

Register author
Teri E Klein

Teri E Klein

Publications by authors named "Teri E Klein"

Are you Teri E Klein?   Register this Author

100Publications

-Reads

Essential characteristics of pharmacogenomics study publications.

Clin Pharmacol Ther 2018 Nov 8. Epub 2018 Nov 8.

Department of Biomedical Data Sciences, Stanford University, CA.

View Article
November 2018

PharmGKB summary: oxycodone pathway, pharmacokinetics.

Pharmacogenet Genomics 2018 Oct;28(10):230-237

Departments of Biomedical Data Sciences.

View Article
October 2018

PharmGKB summary: clozapine pathway, pharmacokinetics.

Pharmacogenet Genomics 2018 Sep;28(9):214-222

Departments of Biomedical Data Sciences.

View Article
September 2018

PharmCAT: A Pharmacogenomics Clinical Annotation Tool.

Clin Pharmacol Ther 2018 Jul 1;104(1):19-22. Epub 2017 Dec 1.

Biomedical and Translational Informatics Institute, Geisinger, Danville, Pennsylvania, USA.

View Article
July 2018

PharmGKB: A worldwide resource for pharmacogenomic information.

Wiley Interdiscip Rev Syst Biol Med 2018 07 23;10(4):e1417. Epub 2018 Feb 23.

Department of Biomedical Data Sciences, Stanford University, Stanford, California.

View Article
July 2018

Standardization can accelerate the adoption of pharmacogenomics: current status and the path forward.

Pharmacogenomics 2018 Jul 19;19(10):847-860. Epub 2018 Jun 19.

Department of Pharmaceutical Sciences, St Jude Children's Research Hospital, Memphis, TN 38105, USA.

View Article
July 2018

Substitutions for arginine at position 780 in triple helical domain of the α1(I) chain alter folding of the type I procollagen molecule and cause osteogenesis imperfecta.

PLoS One 2018 10;13(7):e0200264. Epub 2018 Jul 10.

Section on Physical Biochemistry, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, United States of America.

View Article
July 2018

PharmGKB summary: atazanavir pathway, pharmacokinetics/pharmacodynamics.

Pharmacogenet Genomics 2018 May;28(5):127-137

Departments of Biomedical Data Science.

View Article
May 2018

Pharmacogenomics and big genomic data: from lab to clinic and back again.

Hum Mol Genet 2018 May;27(R1):R72-R78

Department of Genetics, Stanford University, Stanford, CA 94305, USA.

View Article
May 2018

PharmGKB summary: clobazam pathway, pharmacokinetics.

Pharmacogenet Genomics 2018 Apr;28(4):110-115

Departments of Biomedical Data Sciences.

View Article
April 2018

The Pharmacogene Variation (PharmVar) Consortium: Incorporation of the Human Cytochrome P450 (CYP) Allele Nomenclature Database.

Clin Pharmacol Ther 2018 Mar 14;103(3):399-401. Epub 2017 Nov 14.

Department of Genetics, Stanford University, Stanford, California, USA.

View Article
March 2018

Response to "Impact of CYP3A4 Genotype on Voriconazole Exposure: New Insights Into the Contribution of CYP3A4*22 to Metabolism of Voriconazole".

Clin Pharmacol Ther 2018 Feb 16;103(2):187. Epub 2017 Nov 16.

Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.

View Article
February 2018

PharmGKB summary: very important pharmacogene information for ABCG2.

Pharmacogenet Genomics 2017 11;27(11):420-427

Departments of aGenetics bBioengineering, School of Medicine, Stanford University, Stanford cDepartment of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, USA.

View Article
November 2017

PharmGKB summary: pazopanib pathway, pharmacokinetics.

Pharmacogenet Genomics 2017 08;27(8):307-312

Departments of aBiomedical Data Sciences bBiomedical Engineering cGenetics, Stanford University, Stanford, California dDepartment of Medicine, University of Chicago, Chicago, Illinois, USA.

View Article
August 2017

PharmGKB summary: sorafenib pathways.

Pharmacogenet Genomics 2017 06;27(6):240-246

Departments of aBiomedical Data Science bBiomedical Engineering cGenetics Stanford University, Stanford dGilead Sciences, Foster City eEvviva Sciences, San Francisco, California fInova Schar Cancer Institute and Therapeutics, Center for Personalized Health, Falls Church, Virginia, USA.

View Article
June 2017

PharmGKB summary: voriconazole pathway, pharmacokinetics.

Pharmacogenet Genomics 2017 05;27(5):201-209

Departments of aBiomedical Data Science bBioengineering, Stanford University, Stanford, California cIcahn School of Medicine at Mount Sinai, The Charles Bronfman Institute for Personalized Medicine dDepartment of Medicine, Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai eDepartment of Pharmacy, The Mount Sinai Hospital, New York, New York, USA.

View Article
May 2017

PharmGKB summary: Macrolide antibiotic pathway, pharmacokinetics/pharmacodynamics.

Pharmacogenet Genomics 2017 04;27(4):164-167

Departments of aGenetics bBioengineering, School of Medicine, Stanford University, Stanford, California cDivision of Pharmaceutics, College of Pharmacy and Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA.

View Article
April 2017

PharmGKB summary: ivacaftor pathway, pharmacokinetics/pharmacodynamics.

Pharmacogenet Genomics 2017 01;27(1):39-42

Departments of aGenetics bBioengineering, Stanford University, Stanford, California cDepartment of Pediatrics, Cincinnati Children's Hospital Medical Center and University of Cincinnati, Cincinnati, Ohio, USA dGenomics England, Queen Mary University of London, London, UK.

View Article
January 2017

PharmGKB summary: very important pharmacogene information for MT-RNR1.

Pharmacogenet Genomics 2016 12;26(12):558-567

Departments of aGenetics bBioengineering, Stanford University, Stanford, California cDepartment of Pediatrics, Division of Medical Genetics and Genomic Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.

View Article
December 2016

Evidence and resources to implement pharmacogenetic knowledge for precision medicine.

Am J Health Syst Pharm 2016 Dec;73(23):1977-1985

Pharmacogenomics Knowledgebase (PharmGKB), Stanford University School of Medicine, Palo Alto, CA.

View Article
December 2016

PharmGKB summary: isoniazid pathway, pharmacokinetics.

Pharmacogenet Genomics 2016 09;26(9):436-44

Departments of aGenetics bBioengineering, Stanford University, Stanford cKeck School of Medicine of University of Southern California, Los Angeles, California, USA dDepartment of Molecular Biology and Genetics, Democritus University of Thrace, Alexandroupolis, Greece eDepartment of Pharmacology, University of Oxford, Oxford, UK.

View Article
September 2016

Population-specific single-nucleotide polymorphism confers increased risk of venous thromboembolism in African Americans.

Mol Genet Genomic Med 2016 Sep 21;4(5):513-20. Epub 2016 Jun 21.

Department of GeneticsStanford University School of MedicineStanfordCalifornia94305; Department of BioengineeringStanford University School of MedicineStanfordCalifornia94305.

View Article
September 2016

Developing knowledge resources to support precision medicine: principles from the Clinical Pharmacogenetics Implementation Consortium (CPIC).

J Am Med Inform Assoc 2016 07 28;23(4):796-801. Epub 2016 Mar 28.

Departments of Medicine and Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA.

View Article
July 2016

A twentieth anniversary tribute to PSB.

Pac Symp Biocomput 2015 :1-7

Stanford University, Shriram Center for Bioengineering and Chemical Engineering, 443 Via Ortega, Stanford, CA 94305, USA.

View Article
April 2016

PharmGKB summary: very important pharmacogene information for RYR1.

Pharmacogenet Genomics 2016 Mar;26(3):138-44

Departments of aGenetics bBioengineering, Stanford University, Stanford cChildren's Hospital Oakland Research Institute and UCSF, Oakland, California dDepartment of Medicine, University of North Dakota, Fargo, North Dakota eIMAGENETICS, Sanford Healthcare, Sioux Falls, South Dakota, USA.

View Article
March 2016

PharmGKB summary: succinylcholine pathway, pharmacokinetics/pharmacodynamics.

Pharmacogenet Genomics 2015 Dec;25(12):622-30

Departments of aGenetics bBioengineering, Stanford University, Stanford, California cDepartment of Anesthesiology dMoffitt Cancer Center, DeBartolo Family Personalized Medicine Institute, Tampa, Florida, USA eGenomics England, Queen Mary University of London, London, UK.

View Article
December 2015

Sequence to Medical Phenotypes: A Framework for Interpretation of Human Whole Genome DNA Sequence Data.

PLoS Genet 2015 Oct 8;11(10):e1005496. Epub 2015 Oct 8.

Stanford Center for Inherited Cardiovascular Disease, Stanford University, Stanford, California, United States of America; Stanford Cardiovascular Institute, Stanford University, Stanford, California, United States of America; Division of Cardiovascular Medicine, Stanford University, Stanford, California, United States of America; Department of Genetics, Stanford University, Stanford, California, United States of America.

View Article
October 2015

PharmGKB summary: peginterferon-α pathway.

Pharmacogenet Genomics 2015 Sep;25(9):465-74

Departments of aGenetics bBioengineering, Stanford University, Stanford, California cDuke Clinical Research Institute, Duke University, Durham, North Carolina, USA.

View Article
September 2015

PharmGKB summary: pathways of acetaminophen metabolism at the therapeutic versus toxic doses.

Pharmacogenet Genomics 2015 Aug;25(8):416-26

aDepartment of Systems Pharmacology and Translational Therapeutics, Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania Departments of bGenetics cBioengineering, Stanford University Medical Center, Stanford University, Stanford, California, USA.

View Article
August 2015

PharmGKB summary: Efavirenz pathway, pharmacokinetics.

Pharmacogenet Genomics 2015 Jul;25(7):363-76

Departments of aGenetics bBioengineering, School of Medicine, Stanford University, Stanford, California, USA cDepartment of Immunology, University of Toronto, Toronto, Ontario, Canada.

View Article
July 2015

Evidence for Clinical Implementation of Pharmacogenomics in Cardiac Drugs.

Mayo Clin Proc 2015 Jun;90(6):716-29

Center for Personalized Therapeutics, The University of Chicago, Chicago, IL; Department of Medicine, The University of Chicago, Chicago, IL; Committee on Clinical Pharmacology and Pharmacogenomics, The University of Chicago, Chicago, IL. Electronic address:

View Article
June 2015

PharmGKB summary: very important pharmacogene information for human leukocyte antigen B.

Pharmacogenet Genomics 2015 Apr;25(4):205-21

Departments of aGenetics bBioengineering, Stanford University, Stanford cDepartment of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, USA.

View Article
April 2015

PharmGKB summary: very important pharmacogene information for CFTR.

Pharmacogenet Genomics 2015 Mar;25(3):149-56

Departments of aGenetics, Stanford School of Medicine bBioengineering, Stanford University, Stanford, California cDivision of Pulmonary Medicine, Cincinnati Children's Hospital Medical Center dDepartment of Pediatrics, University of Cincinnati, Cincinnati, Ohio, USA.

View Article
March 2015

PharmGKB summary: ibuprofen pathways.

Pharmacogenet Genomics 2015 Feb;25(2):96-106

aDepartment of Systems Pharmacology and Translational Therapeutics bInstitute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania Departments of cGenetics dBioengineering, Stanford University, Stanford, California, USA.

View Article
February 2015

Evidence synthesis and guideline development in genomic medicine: current status and future prospects.

Genet Med 2015 Jan 19;17(1):63-7. Epub 2014 Jun 19.

1] Epidemiology and Genomics Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland, USA [2] Office of Public Health Genomics, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

View Article
January 2015

PharmGKB summary: very important pharmacogene information for CYP4F2.

Pharmacogenet Genomics 2015 Jan;25(1):41-7

Departments of aGenetics bBioengineering, Stanford University, Stanford, California, USA.

View Article
January 2015

PharmGKB summary: gemcitabine pathway.

Pharmacogenet Genomics 2014 Nov;24(11):564-74

Departments of aGenetics bBioengineering, Stanford University, Stanford, California, USA cDepartment of Pharmacotherapy and Translational Research dCenter for Pharmacogenomics, College of Pharmacy, University of Florida, Gainesville, Florida eDepartment of Molecular Pharmacology & Experimental Therapeutics, Division of Clinical Pharmacology, Mayo Clinic, Rochester, Minnesota, USA.

View Article
November 2014

PharmGKB summary: uric acid-lowering drugs pathway, pharmacodynamics.

Pharmacogenet Genomics 2014 Sep;24(9):464-76

Departments of aGenetics bBioengineering, Stanford University, Stanford, California cACOS for Research, Department of Veterans Affairs Medical Center Departments of dMedicine ePharmacology/Toxicology, Indiana University School of Medicine, Indianapolis, Indiana, USA.

View Article
September 2014

PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2.

Pharmacogenet Genomics 2014 Aug;24(8):409-25

Departments of aGenetics bBioengineering, Stanford University, Palo Alto, California cDepartment of Pharmacology and Toxicology and James Graham Brown Cancer Center, University of Louisville, Kentucky, USA dDepartment of Molecular Biology and Genetics, Democritus University of Thrace, Alexandroupolis, Greece eDepartment of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Stockholm, Sweden.

View Article
August 2014

PharmGKB summary: tramadol pathway.

Pharmacogenet Genomics 2014 Jul;24(7):374-80

Departments of aGenetics bBioengineering, Stanford University, Stanford, California, USA cDepartment of Anaesthesiology and Pain Medicine, Inselspital dDepartment of Clinical Research, University of Bern, Bern, Switzerland eInstitute of Clinical Pharmacology, University Medical Center, Göttingen, Germany.

View Article
July 2014

PharmGKB summary: very important pharmacogene information for SLC22A1.

Pharmacogenet Genomics 2014 Jun;24(6):324-8

aDepartment of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco Departments of bGenetics cBioengineering, Stanford University, Palo Alto, California, USA.

View Article
June 2014

PharmGKB summary: abacavir pathway.

Pharmacogenet Genomics 2014 May;24(5):276-82

Departments of aGenetics bBioengineering, Stanford University, Stanford cDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco, California, USA.

View Article
May 2014

PharmGKB summary: very important pharmacogene information for UGT1A1.

Pharmacogenet Genomics 2014 Mar;24(3):177-83

Departments of aGenetics bBioengineering, Stanford University, Palo Alto, California, USA cDepartment of Pharmaceutical Sciences, St Jude Children's Research Hospital, Memphis, Tennessee, USA.

View Article
March 2014

Clinical interpretation and implications of whole-genome sequencing.

JAMA 2014 Mar;311(10):1035-45

Stanford Center for Inherited Cardiovascular Disease, Stanford, California2Stanford Cardiovascular Institute, Stanford, California3Division of Cardiovascular Medicine, Stanford University, Stanford, California4Stanford Center for Genomics and Personalized.

View Article
March 2014

PharmGKB: the Pharmacogenomics Knowledge Base.

Methods Mol Biol 2013 ;1015:311-20

Department of Genetics, School of Medicine, Stanford University, Stanford, CA, USA.

View Article
February 2014

PharmGKB summary: ifosfamide pathways, pharmacokinetics and pharmacodynamics.

Pharmacogenet Genomics 2014 Feb;24(2):133-8

Departments of aGenetics bBioengineering, Stanford University Medical Center, Stanford, California cDepartments of Medicine, Indiana University Simon Cancer Center, Indianapolis, Indiana, USA.

View Article
February 2014

Re: CYP2D6 genotyping and the use of tamoxifen in breast cancer.

J Natl Cancer Inst 2014 Feb 9;106(2):djt379. Epub 2014 Jan 9.

Affiliations of authors: Center for Genome Sciences and Systems Biology, Washington University School of Medicine, St. Louis, MO (MAP); PharmGKB, Stanford University, Palo Alto, CA (TEK).

View Article
February 2014

PharmGKB summary: venlafaxine pathway.

Pharmacogenet Genomics 2014 Jan;24(1):62-72

Departments of aGenetics bBioengineering, Stanford University, Stanford, California, USA cInstitute of Pharmacology of Natural Products & Clinical Pharmacology, University of Ulm, Ulm dResearch Division, Federal Institute of Drugs & Medical Devices (BfArM), Bonn, Germany eDepartment of Pharmacology and Toxicology, Institute of Biomedicine, University of Oulu, Oulu, Finland.

View Article
January 2014

PharmGKB summary: mycophenolic acid pathway.

Pharmacogenet Genomics 2014 Jan;24(1):73-9

aDepartment of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota Departments of bGenetics cBioengineering, Stanford University Medical Center, Stanford University, Stanford, California, USA.

View Article
January 2014

PharmGKB summary: very important pharmacogene information for cytochrome P450, family 2, subfamily C, polypeptide 8.

Pharmacogenet Genomics 2013 Dec;23(12):721-8

aDepartment of Pharmaceutical Sciences, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, Colorado Departments of bGenetics cBioengineering, Stanford University, Palo Alto, California, USA dDepartment of Clinical Pharmacology, University of Helsinki, HUSLAB, Helsinki University Central Hospital, Helsinki, Finland.

View Article
December 2013

Molecular dynamics simulations of the full triple helical region of collagen type I provide an atomic scale view of the protein's regional heterogeneity.

Pac Symp Biocomput 2011 :193-204

Department of Genetics, Stanford University, 1501 S. California Avenue, Palo Alto, CA 94304, USA.

View Article
November 2013

PharmGKB summary: tamoxifen pathway, pharmacokinetics.

Pharmacogenet Genomics 2013 Nov;23(11):643-7

Departments of aGenetics bBioengineering, Stanford University Medical Center, Stanford, California cDepartment of Medicine, Indiana University Simon Cancer Center, Indianapolis, Indiana, USA.

View Article
November 2013

PharmGKB summary: very important pharmacogene information for the epidermal growth factor receptor.

Pharmacogenet Genomics 2013 Nov;23(11):636-42

Departments of aGenetics bBioengineering, Stanford University Medical Center, Stanford, California, USA cBreakthrough Cancer Research Unit, Pangaea Biotech, Dexeus University Institute dMedical Oncology Service, Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Barcelona, Spain.

View Article
November 2013

PharmGKB summary: cyclosporine and tacrolimus pathways.

Pharmacogenet Genomics 2013 Oct;23(10):563-85

Departments of aGenetics bBioengineering, Stanford University, Stanford, California cDepartment of Pharmaceutical Sciences, School of Pharmacy dDepartment of Pathology, School of Medicine, Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, Pennsylvania, USA eSchool of Pharmacy, University of Queensland, Brisbane, Australia.

View Article
October 2013

PharmGKB summary: methylene blue pathway.

Pharmacogenet Genomics 2013 Sep;23(9):498-508

Department of Genetics, Stanford University, Palo Alto, CA 94304, USA.

View Article
September 2013

The Pharmacogenomics Research Network Translational Pharmacogenetics Program: overcoming challenges of real-world implementation.

Clin Pharmacol Ther 2013 Aug 19;94(2):207-10. Epub 2013 Mar 19.

Program in Personalized and Genomic Medicine and Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.

View Article
August 2013

PharmGKB summary: Diuretics pathway, pharmacodynamics.

Pharmacogenet Genomics 2013 Aug;23(8):449-53

Department of Genetics, Stanford University Medical Center, Stanford, California 94305-5120, USA.

View Article
August 2013

Pharmacogenetics of warfarin: challenges and opportunities.

J Hum Genet 2013 Jun 9;58(6):334-8. Epub 2013 May 9.

Laboratory for International Alliance, RIKEN Center for Genomic Medicine, Yokohama, Japan.

View Article
June 2013

Valproic acid pathway: pharmacokinetics and pharmacodynamics.

Pharmacogenet Genomics 2013 Apr;23(4):236-41

Department of Experimental and Clinical Pharmacology, University of Minnesota-Twin Cities, Minneapolis, Minnesota, USA.

View Article
April 2013

Nomenclature for alleles of the thiopurine methyltransferase gene.

Pharmacogenet Genomics 2013 Apr;23(4):242-8

Department of Medical and Health Sciences, Division of Drug Research, Faculty of Health Sciences, Linköping University, Linköping, Sweden.

View Article
April 2013

PharmGKB summary: zidovudine pathway.

Pharmacogenet Genomics 2012 Dec;22(12):891-4

Department of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, Minnesota, USA.

View Article
December 2012

Metformin pathways: pharmacokinetics and pharmacodynamics.

Pharmacogenet Genomics 2012 Nov;22(11):820-7

Department of Genetics, Stanford University Medical Center, Stanford University, Stanford, California 94304, USA.

View Article
November 2012

Very important pharmacogene summary for VDR.

Pharmacogenet Genomics 2012 Oct;22(10):758-63

Channing Laboratory, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts, USA.

View Article
October 2012

PharmGKB summary: very important pharmacogene information for GSTT1.

Pharmacogenet Genomics 2012 Aug;22(8):646-51

Department of Genetics, Stanford University Medical Center, Stanford, California, USA.

View Article
August 2012

PharmGKB summary: very important pharmacogene information for CYP3A5.

Pharmacogenet Genomics 2012 Jul;22(7):555-8

Department of Experimental and Clinical Pharmacology, College of Pharmacy, Institute of Human Genetics, University of Minnesota, Minnesota, USA.

View Article
July 2012

Using ODIN for a PharmGKB revalidation experiment.

Database (Oxford) 2012 23;2012:bas021. Epub 2012 Apr 23.

Institute of Computational Linguistics, Binzmuhlestrasse 171, 8050 Zurich, Switzerland.

View Article
June 2012

PharmGKB summary: phenytoin pathway.

Pharmacogenet Genomics 2012 Jun;22(6):466-70

Department of Genetics, Stanford University Medical Center, Stanford, California, USA.

View Article
June 2012

PharmGKB summary: caffeine pathway.

Pharmacogenet Genomics 2012 May;22(5):389-95

Department of Genetics, Stanford University Medical Center, Stanford, California 94305-5120, USA.

View Article
May 2012

Celecoxib pathways: pharmacokinetics and pharmacodynamics.

Pharmacogenet Genomics 2012 Apr;22(4):310-8

Department of Genetics, Stanford University, Stanford, California, USA.

View Article
April 2012

PharmGKB summary: very important pharmacogene information for G6PD.

Pharmacogenet Genomics 2012 Mar;22(3):219-28

Department of Genetics, Stanford University, California, USA.

View Article
March 2012

PharmGKB summary: very important pharmacogene information for cytochrome P450, family 2, subfamily C, polypeptide 19.

Pharmacogenet Genomics 2012 Feb;22(2):159-65

Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York, New York, USA.

View Article
February 2012

PharmGKB summary: very important pharmacogene information for CYP1A2.

Pharmacogenet Genomics 2012 Jan;22(1):73-7

Department of Genetics, Stanford University Medical Center, Stanford, California 94305-5120, USA.

View Article
January 2012

PharmGKB summary: carbamazepine pathway.

Pharmacogenet Genomics 2011 Dec;21(12):906-10

Department of Genetics, Stanford University Medical Center, Stanford, California 94305-5120, USA.

View Article
December 2011

From pharmacogenomic knowledge acquisition to clinical applications: the PharmGKB as a clinical pharmacogenomic biomarker resource.

Biomark Med 2011 Dec;5(6):795-806

Department of Genetics, Stanford University, 1501 S California Avenue, Palo Alto, CA 94304, USA.

View Article
December 2011

PharmGKB summary: citalopram pharmacokinetics pathway.

Pharmacogenet Genomics 2011 Nov;21(11):769-72

Department of Genetics, Stanford University, Stanford, California, USA.

View Article
November 2011

PharmGKB summary: very important pharmacogene information for PTGS2.

Pharmacogenet Genomics 2011 Sep;21(9):607-13

Department of Genetics, Stanford University Medical Center, Stanford, California 94305-5120, USA.

View Article
September 2011

Platelet aggregation pathway.

Pharmacogenet Genomics 2011 Aug;21(8):516-21

Department of Genetics, Stanford University, Stanford, California, USA.

View Article
August 2011

Doxorubicin pathways: pharmacodynamics and adverse effects.

Pharmacogenet Genomics 2011 Jul;21(7):440-6

Departments of Genetics, Stanford University Medical Center, California 94305-5120, USA.

View Article
July 2011